FDA Inspection 1231029 — Abeona Therapeutics, Inc.
The FDA completed an inspection of Abeona Therapeutics, Inc. on Jan 24, 2024 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 24, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Cleveland, OH (United States)
Additional Details
Sponsor, Contract Research Organization